Search results for: 'Biologics Contract Development and Manufacturing'

The COVID-19 pandemic marked a major global change, revolutionizing manufacturing. Political tensions, such as the US-China conflict and the Russo-Ukrainian war; economic uncertainties, such as high inflation rates and de-dollarization initiatives; and continuous supply chain disruptions force manufacturers to invest in technology to secure reliabl...

Radical changes in science and technology are helping the human body evolve. Biological augmentations and body enhancements are transforming the human body and bringing about a kind of transhumanism by eliminating diseases, extending life spans, and enhancing human capabilities. Biological augmentations and body enhancements are classified into th...

08 Jun 2022  |  North America  |  Market Research

Growth Opportunities in Sterile Injectable Outsourcing

Biologics Drive the Future Growth Potential of Sterile Injectable Outsourcing

Infographics

×

Injectables constitute one of the fastest growing segments in the pharmaceuticals space. Many drugs, including biologics, are going off patent in next 3 or 4 years, which will lead to an increase in the demand for generics and biosimilar injectables. The increase in onshoring and nearshoring of biopharmaceutical products for COVID-19 and next-gen...

According to the International Energy Agency (IEA), the aviation industry accounts for 2% of global carbon emissions. Total cumulative emissions reached approximately 800 million tons in 2022, and cumulative emissions are expected to reach approximately 1,750-2,000 million tons by 2050. The International Air Transport Association (IATA) has committ...

More than 6,000 molecules are currently in clinical development across the pharmaceutical research and development (R&D) landscape, with more than 11,000 in the preclinical phase. The industry is witnessing the growth of small- to mid-segment pharma/biotech players making significant contributions to drug discovery and development pipelines. Across...

Buildings are becoming more energy-intensive and with features like electric vehicle charging adding to the existing load, the need to reduce energy consumption acquires an even greater importance. Energy saving and performance contracting (ESPC) is one way to achieve energy efficiency. In that sense, North America has been the second-largest marke...

Continuous manufacturing (CM) is a method for manufacturing end-to-end pharmaceutical products on a single, uninterrupted production line. While batch manufacturing requires transporting, testing, and refeeding materials from one process to the next, continuous processes execute all testing, feeding, and processing inline at a single manufacturing ...

Frost & Sullivan has a long and successful track record covering the Industrial Automation and Manufacturing landscape, delivering best-in-class market intelligence and anticipating the market and technology trends that shape these industries to identify the most significant growth opportunities. Two breakthrough events have changed the landscap...

The Microelectronics Technology Opportunity Engine covers innovations pertaining to Advanced Memory, Processors, Chip Manufacturing, and Compound Semiconductors among many others.The Microelectronics Technology Opportunity Engine captures global electronics-related innovations and developments on a weekly basis. Developments are centered on electro...